v3.26.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Shares beginning at Dec. 31, 2024 [1]   2,416,066    
Balance beginning at Dec. 31, 2024 $ 14,478 $ 7 [1] $ 136,127 $ (121,656)
Stock issued during period shares new issues, amount 3,735 $ 1 [1] 3,734  
Stock issued during period shares new issues, shares [1]   245,428    
Issuance of common stock upon exercise of Series C warrants, net of issuance costs, Shares [1]   47,088    
Issuance of common stock upon exercise of Series C warrants, net of issuance costs 383   383  
Stock-based compensation expense 831   831  
Net Income (Loss) (5,550)     (5,550)
Shares ending at Mar. 31, 2025 [1]   2,708,582    
Balance ending at Mar. 31, 2025 13,877 $ 8 [1] 141,075 (127,206)
Payment of issuance costs from December 2025 issuance of common stock 0      
Shares beginning at Dec. 31, 2024 [1]   2,416,066    
Balance beginning at Dec. 31, 2024 14,478 $ 7 [1] 136,127 (121,656)
Net Income (Loss) (10,644)      
Shares ending at Jun. 30, 2025 [1]   4,078,139    
Balance ending at Jun. 30, 2025 15,239 $ 10 [1] 147,529 (132,300)
Shares beginning at Mar. 31, 2025 [1]   2,708,582    
Balance beginning at Mar. 31, 2025 13,877 $ 8 [1] 141,075 (127,206)
Stock issued during period shares new issues, amount 3,617 $ 2 [1] 3,615  
Stock issued during period shares new issues, shares [1]   1,058,861    
Issuance of common stock upon exercise of Series A&B warrants, net of issuance costs , Share [1]   310,696    
Issuance of common stock upon exercise of Series A&B warrants, net of issuance costs 1,884   1,884  
Stock-based compensation expense 955   955  
Net Income (Loss) (5,094)     (5,094)
Shares ending at Jun. 30, 2025 [1]   4,078,139    
Balance ending at Jun. 30, 2025 15,239 $ 10 [1] 147,529 (132,300)
Payment of issuance costs from December 2025 issuance of common stock (88)   (88)  
Shares beginning at Dec. 31, 2025 [1]   9,766,132    
Balance beginning at Dec. 31, 2025 27,558 $ 10 [1] 168,644 (141,096)
Issuance of common stock upon exercise of Series A warrants, net of issuance costs , Share [1]   80,957    
Issuance of common stock upon exercise of Series A warrants, net of issuance costs 0   0  
Stock-based compensation expense 401   401  
Net Income (Loss) (5,090)     (5,090)
Shares ending at Mar. 31, 2026 [1]   9,847,089    
Balance ending at Mar. 31, 2026 22,781 $ 10 [1] 168,957 (146,186)
Payment of issuance costs from December 2025 issuance of common stock (77)      
Shares beginning at Dec. 31, 2025 [1]   9,766,132    
Balance beginning at Dec. 31, 2025 27,558 $ 10 [1] 168,644 (141,096)
Net Income (Loss) (9,871)      
Shares ending at Jun. 30, 2026 [1]   9,853,121    
Balance ending at Jun. 30, 2026 18,363 $ 10 [1] 169,320 (150,967)
Shares beginning at Mar. 31, 2026 [1]   9,847,089    
Balance beginning at Mar. 31, 2026 22,781 $ 10 [1] 168,957 (146,186)
Stock issued during period shares new issues, amount 11   11  
Stock issued during period shares new issues, shares [1]   6,032    
Stock-based compensation expense 352   352  
Net Income (Loss) (4,781)     (4,781)
Shares ending at Jun. 30, 2026 [1]   9,853,121    
Balance ending at Jun. 30, 2026 $ 18,363 $ 10 [1] $ 169,320 $ (150,967)
[1] All share amounts and per share amounts disclosed in this Quarterly Report on Form 10-Q have been restated to reflect a one-for-thirty reverse stock split effected in June 2025. See Note 1, Organization and Nature of Operations, for details.